AU2002239505A1 - Methods and compositions for the diagnosis and treatment of viral disease using 55092 - Google Patents
Methods and compositions for the diagnosis and treatment of viral disease using 55092Info
- Publication number
- AU2002239505A1 AU2002239505A1 AU2002239505A AU3950502A AU2002239505A1 AU 2002239505 A1 AU2002239505 A1 AU 2002239505A1 AU 2002239505 A AU2002239505 A AU 2002239505A AU 3950502 A AU3950502 A AU 3950502A AU 2002239505 A1 AU2002239505 A1 AU 2002239505A1
- Authority
- AU
- Australia
- Prior art keywords
- diagnosis
- compositions
- treatment
- methods
- viral disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5761—Hepatitis B
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25403700P | 2000-12-07 | 2000-12-07 | |
US60/254,037 | 2000-12-07 | ||
PCT/US2001/046358 WO2002045570A2 (en) | 2000-12-07 | 2001-12-06 | Methods and compositions for the diagnosis and treatment of viral disease using 55092 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002239505A1 true AU2002239505A1 (en) | 2002-06-18 |
Family
ID=22962691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002239505A Abandoned AU2002239505A1 (en) | 2000-12-07 | 2001-12-06 | Methods and compositions for the diagnosis and treatment of viral disease using 55092 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20020146686A1 (en) |
EP (1) | EP1392855A4 (en) |
AU (1) | AU2002239505A1 (en) |
WO (1) | WO2002045570A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2709741C2 (en) * | 2013-07-30 | 2019-12-19 | ЭсБиАй БАЙОТЕК КО., ЛТД. | Medicinal agent containing phospholipase d4 antibody |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1632499E (en) * | 1999-03-08 | 2007-09-11 | Genentech Inc | Gene sequences amplified in tumours and their diagnostic uses |
US20030124575A1 (en) * | 2000-03-29 | 2003-07-03 | Gudrun Werner | Organic compounds |
-
2001
- 2001-12-06 AU AU2002239505A patent/AU2002239505A1/en not_active Abandoned
- 2001-12-06 EP EP01987270A patent/EP1392855A4/en not_active Withdrawn
- 2001-12-06 US US10/010,943 patent/US20020146686A1/en not_active Abandoned
- 2001-12-06 WO PCT/US2001/046358 patent/WO2002045570A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002045570A2 (en) | 2002-06-13 |
WO2002045570A9 (en) | 2002-10-24 |
EP1392855A2 (en) | 2004-03-03 |
EP1392855A4 (en) | 2005-05-25 |
WO2002045570A3 (en) | 2003-01-23 |
US20020146686A1 (en) | 2002-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001271973A1 (en) | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis | |
AU2001278852A1 (en) | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis | |
AU2001249835A1 (en) | Diagnosis and treatment of alzheimer's disease | |
AU7722600A (en) | Compositions and methods for the diagnosis and treatment of immune disorders | |
AU2001249329A1 (en) | Lipoxin analogs and methods for the treatment of periodontal disease | |
EP1129217A4 (en) | Compositions and methods of disease diagnosis and therapy | |
ZA200301204B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
AU2002335794A1 (en) | Allylamides useful in the treatment of alzheimer's disease | |
AU5309600A (en) | Compositions and methods for the treatment and diagnosis of immune disorders | |
AU3632600A (en) | Compositions and methods for the treatment of immune related diseases | |
AU8678501A (en) | Compositions and methods for the diagnosis and treatment of tumor | |
MXPA03003741A (en) | Methods and compositions for the treatment of diseases of the eye. | |
AU2001257406A1 (en) | Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941 | |
AU2002222108A1 (en) | Diagnosis and treatment of alzheimer's disease | |
AU4228000A (en) | Methods and compositions for the treatment and prevention of lung disease | |
AU3434601A (en) | Compositions and methods for the treatment of immune related diseases | |
AU2001255730A1 (en) | Methods and compositions for the treatment of cardiac indications | |
AU4225500A (en) | Methods and compositions for the treatment and prevention of lung disease | |
AU2002239505A1 (en) | Methods and compositions for the diagnosis and treatment of viral disease using 55092 | |
AU5611701A (en) | Agent for the diagnosis and therapy of viral diseases | |
AU4841296A (en) | Diagnosis of and compositions and methods for the treatment of disease | |
AU2001255168A1 (en) | Compositions and methods for the treatment of immune related diseases | |
AU2002348324A1 (en) | Methods and compositions for the treatment and diagnosis of pain disorders using 46566 | |
AU2002232433A1 (en) | Methods and compositions for diagnosis and treatment of cancer using arginine m ethyltransferase 3 | |
AU2001241778A1 (en) | Methods and compositions for the diagnosis and treatment of cardiovascular, hepatic, and bone disease |